Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 405

Results For "IT"

10433 News Found

DSS Imagetech to host webinar series on advanced imaging technologies
News | April 25, 2026

DSS Imagetech to host webinar series on advanced imaging technologies

The webinar series will showcase next-gen imaging technologies, global expert insights, and hands-on sessions on microscopy innovations


Nihilent launches nSEPIA Beta, introduces AI-driven emotional wellness platform
Digitisation | April 25, 2026

Nihilent launches nSEPIA Beta, introduces AI-driven emotional wellness platform

AI-powered platform uses real-time emotion scanning and personalised interventions to make emotional wellness measurable and actionable


Bayer’s comeback gains speed as CEO warns: “The Work Isn’t Complete. Yet
News | April 25, 2026

Bayer’s comeback gains speed as CEO warns: “The Work Isn’t Complete. Yet"

The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before


Takara Bio, Resistomap join forces to streamline AMR surveillance from environmental samples
R&D | April 24, 2026

Takara Bio, Resistomap join forces to streamline AMR surveillance from environmental samples

Collaboration integrates SmartChip PCR technology with cloud-based analytics to enable faster, standardised monitoring of antimicrobial resistance


Novo Nordisk posts strong late-stage results for oral diabetes pill in children and teens
Clinical Trials | April 24, 2026

Novo Nordisk posts strong late-stage results for oral diabetes pill in children and teens

The study evaluated oral semaglutide in young patients with type 2 diabetes and found it delivered a superior reduction in HbA1c


Biocon receives Health Canada approval for Bosaya and Vevzuo biosimilars to Prolia and Xgeva
Biopharma | April 24, 2026

Biocon receives Health Canada approval for Bosaya and Vevzuo biosimilars to Prolia and Xgeva

Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions


Gujarat Themis Biosyn to acquire anti-TB and anti-infective brands from Sanofi for EUR 158 Million
News | April 24, 2026

Gujarat Themis Biosyn to acquire anti-TB and anti-infective brands from Sanofi for EUR 158 Million

Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence


ModeX doses first patients in trial of next-gen T-cell engager for aggressive B-cell lymphoma
Clinical Trials | April 24, 2026

ModeX doses first patients in trial of next-gen T-cell engager for aggressive B-cell lymphoma

The investigational therapy, MDX2003, is designed to go after cancer cells with a multi-pronged immune attack


Shilpa Medicare appoints Dr Vellaian Karuppiah as COO – Formulations
People | April 24, 2026

Shilpa Medicare appoints Dr Vellaian Karuppiah as COO – Formulations

Veteran pharma leader brings 33+ years of experience to drive operational excellence in formulation business


Merck & Google Cloud ink $1 billion AI deal to build “Agentic” pharma future
Digitisation | April 24, 2026

Merck & Google Cloud ink $1 billion AI deal to build “Agentic” pharma future

The collaboration will roll out an “agentic” AI platform across Merck’s research & development, manufacturing, commercial, and corporate operations